Terms: = Colorectal cancer AND MYCN, N-myc, 4613, ENSG00000134323, NMYC, MODED, ODED AND Prognosis
14 results:
1. Antitumor Activity of Piceamycin by Upregulation of n-myc Downstream-Regulated Gene 1 in Human colorectal cancer Cells.
Kyaw KZ; Byun WS; Shin YH; Huynh TH; Lee JY; Bae ES; Park HJ; Oh DC; Lee SK
J Nat Prod; 2022 Dec; 85(12):2817-2827. PubMed ID: 36458922
[TBL] [Abstract] [Full Text] [Related]
2. Thymidylate synthase inhibitor raltitrexed can induce high levels of DNA damage in mycn-amplified neuroblastoma cells.
Yamashita K; Kiyonari S; Tsubota S; Kishida S; Sakai R; Kadomatsu K
Cancer Sci; 2020 Jul; 111(7):2431-2439. PubMed ID: 32415892
[TBL] [Abstract] [Full Text] [Related]
3. NMI promotes cell proliferation through TGFβ/Smad pathway by upregulating STAT1 in colorectal cancer.
Ji D; Feng Y; Peng W; Li J; Gu Q; Zhang Z; Qian W; Wang Q; Zhang Y; Sun Y
J Cell Physiol; 2020 Jan; 235(1):429-441. PubMed ID: 31230364
[TBL] [Abstract] [Full Text] [Related]
4. Identification of high-risk human papillomavirus and Rb/E2F pathway genomic alterations in mutually exclusive subsets of colorectal neuroendocrine carcinoma.
Shamir ER; Devine WP; Pekmezci M; Umetsu SE; Krings G; Federman S; Cho SJ; Saunders TA; Jen KY; Bergsland E; Jones K; Kim GE; Kakar S; Chiu CY; Joseph NM
Mod Pathol; 2019 Feb; 32(2):290-305. PubMed ID: 30237525
[TBL] [Abstract] [Full Text] [Related]
5. n-myc downstream-regulated gene 1 promotes oxaliplatin-triggered apoptosis in colorectal cancer cells via enhancing the ubiquitination of Bcl-2.
Yang X; Zhu F; Yu C; Lu J; Zhang L; Lv Y; Sun J; Zheng M
Oncotarget; 2017 Jul; 8(29):47709-47724. PubMed ID: 28537875
[TBL] [Abstract] [Full Text] [Related]
6. NDRG2, suppressed expression associates with poor prognosis in pancreatic cancer, is hypermethylated in the second promoter in human gastrointestinal cancers.
Yamamura A; Miura K; Karasawa H; Motoi F; Mizuguchi Y; Saiki Y; Fukushige S; Sunamura M; Shibata C; Unno M; Horii A
Biochem Biophys Res Commun; 2017 Feb; 484(1):138-143. PubMed ID: 28093228
[TBL] [Abstract] [Full Text] [Related]
7. LGR5 regulates pro-survival MEK/ERK and proliferative Wnt/β-catenin signalling in neuroblastoma.
Vieira GC; Chockalingam S; Melegh Z; Greenhough A; Malik S; Szemes M; Park JH; Kaidi A; Zhou L; Catchpoole D; Morgan R; Bates DO; Gabb PD; Malik K
Oncotarget; 2015 Nov; 6(37):40053-67. PubMed ID: 26517508
[TBL] [Abstract] [Full Text] [Related]
8. The metastasis suppressor, NDRG1, inhibits "stemness" of colorectal cancer via down-regulation of nuclear β-catenin and CD44.
Wangpu X; Yang X; Zhao J; Lu J; Guan S; Lu J; Kovacevic Z; Liu W; Mi L; Jin R; Sun J; Yue F; Ma J; Lu A; Richardson DR; Wang L; Zheng M
Oncotarget; 2015 Oct; 6(32):33893-911. PubMed ID: 26418878
[TBL] [Abstract] [Full Text] [Related]
9. Protein arginine methyltransferase 5 is a key regulator of the mycn oncoprotein in neuroblastoma cells.
Park JH; Szemes M; Vieira GC; Melegh Z; Malik S; Heesom KJ; Von Wallwitz-Freitas L; Greenhough A; Brown KW; Zheng YG; Catchpoole D; Deery MJ; Malik K
Mol Oncol; 2015 Mar; 9(3):617-27. PubMed ID: 25475372
[TBL] [Abstract] [Full Text] [Related]
10. The metastasis suppressor, n-myc downregulated gene 1 (NDRG1), is a prognostic biomarker for human colorectal cancer.
Mao Z; Sun J; Feng B; Ma J; Zang L; Dong F; Zhang D; Zheng M
PLoS One; 2013; 8(7):e68206. PubMed ID: 23874544
[TBL] [Abstract] [Full Text] [Related]
11. Expression of NDRG2 in human lung cancer and its correlation with prognosis.
Li SJ; Wang WY; Li B; Chen B; Zhang B; Wang X; Chen CS; Zhao QC; Shi H; Yao L
Med Oncol; 2013 Mar; 30(1):421. PubMed ID: 23307246
[TBL] [Abstract] [Full Text] [Related]
12. Prediction of colorectal cancer relapse and prognosis by tissue mRNA levels of NDRG2.
Chu D; Zhang Z; Li Y; Wu L; Zhang J; Wang W; Zhang J
Mol Cancer Ther; 2011 Jan; 10(1):47-56. PubMed ID: 21220491
[TBL] [Abstract] [Full Text] [Related]
13. Correlation of n-myc downstream-regulated gene 1 expression with clinical outcomes of colorectal cancer patients of different race/ethnicity.
Koshiji M; Kumamoto K; Morimura K; Utsumi Y; Aizawa M; Hoshino M; Ohki S; Takenoshita S; Costa M; Commes T; Piquemal D; Harris CC; Tchou-Wong KM
World J Gastroenterol; 2007 May; 13(20):2803-10. PubMed ID: 17569115
[TBL] [Abstract] [Full Text] [Related]
14. Are CD44 variant isoforms involved in human tumour progression?
Günthert U; Stauder R; Mayer B; Terpe HJ; Finke L; Friedrichs K
Cancer Surv; 1995; 24():19-42. PubMed ID: 7553660
[TBL] [Abstract] [Full Text] [Related]
